Zhao P, Liang YL, Belousoff MJ, et al
In general: Baseline testing helps identify pre-existing issues before starting GLP-1 therapy Early follow-up (812 weeks) checks how your body is responding Ongoing testing may be spaced out or symptom-driven if results are stable and you feel well Most clinicians prioritize trend analysis over isolated single results
In October 2023, the Journal of the American Medical Association ( JAMA) examined adverse events associated with GLP-1 RA drugs used for weight loss, and published in an October edition of JAMA Network letter, where they concluded that studies had found increased risks of gastrointestinal adverse disorders, such as gastroparesis and bowel obstruction
Additionally, these medications slow gastric emptying, which contributes to improved postprandial glucose control and promotes satiety
Its vital to understand that Ozempic does not treat ADHD